Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 2/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516136 | 1.00 | TP53 (0.40) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL521312 | 1.00 | TP53 (0.40) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL29362200 | 1.00 | TP53 (0.40) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL196145 | 1.00 | TP53 (0.40) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL29370388 | 1.00 | TP53 (0.40) | TP53CCR8ALDH1A1EPHX2PTGES | |
| Iodide SCHEMBL5616547 | 0.99 | TP53 (0.39) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL15134862 | 0.96 | CCR8 (0.37) | TP53CCR8ALDH1A1EPHX2PTGES | |
| SCHEMBL13853696 | 0.96 | TP53 (0.38) | TP53CCR8ALDH1A1EPHX2RORC | |
| SCHEMBL16997850 | 0.93 | TP53 (0.42) | TP53CCR8ALDH1A1RORCPOLB | |
| SCHEMBL21981702 | 0.92 | CCR8 (0.41) | TP53CCR8ALDH1A1EPHX2RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12527326-B1 | Indoxacarb suspension concentrate formulations | CONTROL SOLUTIONS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| WO-2024155782-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PATHOGENS | KANNAR EARTH SCIENCE, LTD. (US) | 2024-07-25 | — | — | WO | disclosed |
| EP-3629743-B1 | PLANT TREATMENT PRODUCTS AND RELATED METHODS | CYTOZYME LABORATORIES INC (US) | 2023-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527326-B1 | Indoxacarb suspension concentrate formulations | SCN2B, CACNG3, CACNA1G | TP53 4638/4885CCR8 1658/4885ALDH1A1 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.